Table 5.
Biochemical and endocrinologic parameters in subjects with obesity.
| Initial Assessment (Mean ± SEM) |
Annual Assessment (Mean ± SEM) |
p-Value | |
|---|---|---|---|
| Glucose (mg/dL) | 80.11 ± 0.36 | 80.54 ± 0.10 | 0.269 |
| Cholesterol (mg/dL) | 158.57 ± 1.21 | 157.36 ± 1.38 | 0.056 |
| Triglycerides (mg/dL) | 82.36 ± 1.81 | 81.07 ± 1.84 | 0.657 |
| HDL (mg/dL) | 50.23 ± 0.53 | 53.28 ± 0.60 | <0.0001 |
| LDL (mg/dL) | 92.39 ± 1.05 | 89.37 ± 1.14 | <0.0001 |
| ApoA1 (mg/dL) | 140.55 ± 0.96 | 141.60 ± 1.03 | 0.163 |
| ApoB (mg/dL) | 75.59 ± 0.91 | 73.48 ± 0.78 | <0.0001 |
| Lp(a) (mg/dL) | 16.45 ± 0.99 | 15.29 ± 1.05 | 0.031 |
| Adiponectin (ng/mL) | 20,705.41 ± 1203.62 | 23,115.45 ± 1239.64 | 0.008 |
| Insulin (μUI/mL) | 17.52 ± 0.50 | 16.53 ± 0.42 | 0.321 |
| HbA1C (%) | 5.28 ± 0.01 | 5.24 ± 0.01 | <0.0001 |
Abbreviations: ApoA1: Apolipoprotein A1, ApoB: Apolipoprotein B, HbA1C: Hemoglobin A1C, HDL: High-Density Lipoprotein, LDL: Low-Density Lipoprotein, Lp(a): Lipoprotein a.